Effervescent tablet containing povidone and preparation method thereof

By using povidone and specific components formulas in effervescent tablets, combined with reasonable process steps, the problems of long disintegration time and insufficient stability of existing effervescent tablets are solved, and the disintegration speed and stability are achieved Excellent effect extends the absorption and utilization efficiency of vitamins and reduces the hygroscopicity of the acid source.

CN119054856APending Publication Date: 2024-12-03SHANGHAI YUKING WATER SOLUBLE MATERIAL TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411360273.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-26
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing effervescent tablets have a long disintegration time and insufficient stability, which increases the risk of pollution and oxidation. At the same time, the process conditions are unreasonable, resulting in the unstable effervescent tablets produced.

Method used

Using the formula of effervescent tablets containing povidone, polyethylene glycol 6000 is mixed with an alkali source and cooled, crushed and sieved, combining vitamin C, vitamin E, aloe vera freeze-dried powder, acid source, ethanol and gallic acid, etc. Components, combined with specific fillers and sweeteners, through reasonable process steps and component ratios, effervescent tablets with fast disintegration speed and excellent stability are prepared.

Benefits of technology

The disintegration speed and stability of effervescent tablets have been accelerated, and the half-life of vitamin C and vitamin E in plasma has been extended, and the hygroscopicity of the acid source has been reduced, ensuring the good appearance and uniform size of the effervescent tablets have been further improved. Stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005065461730000081
    Figure BDA0005065461730000081
Patent Text Reader

Abstract

The invention belongs to the technical field of health-care food, and provides an effervescent tablet containing povidone and a preparation method of the effervescent tablet. The product comprises the following components in parts by mass: 5-30 parts of vitamin C, 2-15 parts of vitamin E, 10-35 parts of freeze-dried aloe powder, 10-60 parts of an acid source, 5-50 parts of an alkali source, 1-7 parts of povidone, 10-60 parts of ethanol, 3-25 parts of a filling agent, 1-20 parts of a lubricant, 1-10 parts of a sweetening agent and 0.1-1.5 parts of gallic acid. According to the invention, polyethylene glycol 6000 is used for wrapping an alkali source, povidone is used for wrapping an acid source, all procedures are reasonably set, and all the components with specific types and dosages are matched, so that the effervescent tablet which is good in appearance, excellent in stability and high in disintegration speed is finally prepared.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of health food, and in particular to an effervescent tablet containing polyvidone and a preparation method thereof. Background Art

[0002] With the accelerated pace of life and the increase of life pressure, people's lives are getting busier and busier. Irregular diet leads to unbalanced intake of nutrients by most office workers, and the body's immunity is reduced. Therefore, reasonable vitamin supplementation has become one of the hot topics of people's concern. Effervescent tablets refer to tablets containing sodium bicarbonate and organic acids, which can release a large amount of carbon dioxide and effervescent when in contact with water. As soon as the effervescent tablet was invented, it was popular among many people. This is mainly because it is not only easy to carry, but also has a sensory effect when effervescent. More importantly, it can make people take medicine as conveniently as drinking beverages and taste good.

[0003] However, most effervescent tablets currently have a long disintegration time, which prolongs the waiting time for users, thereby increasing the risk of contamination or oxidation caused by contact with the outside world during the disintegration process. In addition, when making existing effervescent tablets, the selection of process conditions is not very reasonable, resulting in insufficient stability of the effervescent tablets.

[0004] In summary, it is of great significance to provide a vitamin effervescent tablet with rapid disintegration and excellent stability. Summary of the invention

[0005] The purpose of the present invention is to overcome the problems existing in the prior art and provide an effervescent tablet containing povidone and a preparation method thereof.

[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0007] The present invention provides an effervescent tablet containing povidone, comprising the following components in parts by weight:

[0008] 5-30 parts of vitamin C, 2-15 parts of vitamin E, 10-35 parts of freeze-dried aloe powder, 10-60 parts of acid source, 5-50 parts of alkali source, 1-7 parts of povidone, 10-60 parts of ethanol, 3-25 parts of filler, 1-20 parts of lubricant, 1-10 parts of sweetener and 0.1-1.5 parts of gallic acid.

[0009] Preferably, the acid source is citric acid; and the alkali source comprises zinc carbonate and sodium bicarbonate.

[0010] Preferably, the mass ratio of zinc carbonate to sodium bicarbonate is 1:0.1-1.

[0011] Preferably, the filler is mannitol; the lubricant comprises polyethylene glycol 6000 and L-leucine; and the sweetener is talose.

[0012] Preferably, the mass ratio of polyethylene glycol 6000 to L-leucine is 1-5:1.

[0013] The present invention also provides a method for preparing the effervescent tablet containing povidone, comprising the following steps:

[0014] (1) heating polyethylene glycol 6000 to obtain melted polyethylene glycol 6000; mixing the melted polyethylene glycol 6000 and an alkali source, and sequentially cooling, crushing and sieving to obtain first particles;

[0015] (2) mixing vitamin C, vitamin E, aloe vera freeze-dried powder, an acid source, povidone, ethanol and gallic acid to prepare a soft material, and sieving and drying the mixture in sequence to obtain a second granule;

[0016] (3) mixing the first granules, the second granules, the filler, L-leucine and the sweetener, and tableting to obtain the effervescent tablet containing povidone;

[0017] There is no specific order between step (1) and step (2).

[0018] Preferably, the heating temperature in step (1) is 70-80° C., the target cooling temperature is 20-30° C., and the mesh size of the sieve is 60-100 meshes.

[0019] Preferably, the mesh size of the sieving in step (2) is 15 to 30 meshes, and the drying temperature is 40 to 60°C.

[0020] Preferably, in step (3), the tabletting temperature is ≤25°C and the tabletting humidity is ≤30%.

[0021] The beneficial effects of the present invention are:

[0022] The present invention provides an effervescent tablet containing polyvidone, comprising the following components by mass: 5-30 parts of vitamin C, 2-15 parts of vitamin E, 10-35 parts of aloe lyophilized powder, 10-60 parts of acid source, 5-50 parts of alkali source, 1-7 parts of polyvidone, 10-60 parts of ethanol, 3-25 parts of filler, 1-20 parts of lubricant, 1-10 parts of sweetener and 0.1-1.5 parts of gallic acid. The addition of aloe lyophilized powder prolongs the half-life of vitamin C and vitamin E in plasma and improves the absorption and utilization efficiency of vitamins in the effervescent tablet; a specific type of filler reduces the hygroscopicity of the acid source, and the two cooperate with each other to improve the disintegration effect and stability of the effervescent tablet; the addition of polyvidone and ethanol improves the disintegration speed of the effervescent tablet, ensuring that the effervescent tablet has a good appearance and uniform size; in addition, the specific types of fillers, sweeteners, polyvidone and gallic acid cooperate with each other to further improve the stability of the effervescent tablet.

[0023] The present invention also provides a method for preparing an effervescent tablet containing povidone, comprising the following steps: heating polyethylene glycol 6000 to obtain molten polyethylene glycol 6000; mixing the molten polyethylene glycol 6000 with an alkali source, sequentially cooling, crushing and sieving to obtain first particles; mixing vitamin C, vitamin E, aloe lyophilized powder, acid source, povidone, ethanol and gallic acid to make a soft material, sequentially sieving and drying to obtain second particles; mixing the first particles, the second particles, a filler, L-leucine and a sweetener, and tableting to obtain an effervescent tablet containing povidone. The present invention encapsulates the alkali source with polyethylene glycol 6000 and the acid source with povidone, and finally prepares an effervescent tablet with good appearance, excellent stability and fast disintegration speed in the present application by reasonably setting each process and coordinating each component of a specific type and amount. DETAILED DESCRIPTION

[0024] The present invention provides an effervescent tablet containing povidone, comprising the following components in parts by weight:

[0025] 5-30 parts of vitamin C, 2-15 parts of vitamin E, 10-35 parts of freeze-dried aloe powder, 10-60 parts of acid source, 5-50 parts of alkali source, 1-7 parts of povidone, 10-60 parts of ethanol, 3-25 parts of filler, 1-20 parts of lubricant, 1-10 parts of sweetener and 0.1-1.5 parts of gallic acid.

[0026] In the present invention, the povidone is preferably povidone k30.

[0027] In the present invention, the mass fraction of vitamin C is 5 to 30 parts, preferably 10 to 25 parts, more preferably 15 to 20 parts, and even more preferably 17 to 18 parts.

[0028] In the present invention, the mass fraction of vitamin E is 2 to 15 parts, preferably 5 to 12 parts, more preferably 7 to 10 parts, and even more preferably 8 to 9 parts.

[0029] In the present invention, the mass fraction of the freeze-dried aloe powder is 10 to 35 parts, preferably 15 to 30 parts, more preferably 20 to 25 parts, and even more preferably 22 to 23 parts.

[0030] In the present invention, the mass fraction of the acid source is 10 to 60 parts, preferably 25 to 50 parts, more preferably 30 to 45 parts, and even more preferably 35 to 36 parts.

[0031] In the present invention, the mass fraction of the alkali source is 5 to 50 parts, preferably 10 to 45 parts, more preferably 20 to 35 parts, and even more preferably 25 to 30 parts.

[0032] In the present invention, the mass fraction of povidone is 1 to 7 parts, preferably 2 to 6 parts, more preferably 3 to 5 parts, and even more preferably 4 parts.

[0033] In the present invention, the mass fraction of ethanol is 10 to 60 parts, preferably 20 to 50 parts, more preferably 30 to 40 parts, and even more preferably 35 parts.

[0034] In the present invention, the mass fraction of the filler is 3 to 25 parts, preferably 5 to 22 parts, more preferably 8 to 20 parts, and even more preferably 10 to 15 parts.

[0035] In the present invention, the mass fraction of the lubricant is 1 to 20 parts, preferably 3 to 18 parts, more preferably 5 to 15 parts, and even more preferably 10 to 12 parts.

[0036] In the present invention, the mass fraction of the sweetener is 1 to 10 parts, preferably 2 to 8 parts, more preferably 3 to 7 parts, and even more preferably 5 to 6 parts.

[0037] In the present invention, the mass fraction of gallic acid is 0.1 to 1.5 parts, preferably 0.3 to 1.2 parts, more preferably 0.5 to 1.0 parts, and even more preferably 0.7 to 0.8 parts.

[0038] In the present invention, the acid source is preferably citric acid; and the alkali source preferably comprises zinc carbonate and sodium bicarbonate.

[0039] In the present invention, zinc carbonate and sodium bicarbonate are used together as alkaline sources, which, on the one hand, reduce the concentration of sodium ions in the effervescent tablet, and on the other hand, zinc carbonate forms bioactive zinc ions after effervescence to supplement the nutrients required by the human body.

[0040] In the present invention, the mass ratio of zinc carbonate to sodium bicarbonate is preferably 1:0.1-1, more preferably 1:0.3-0.8, and more preferably 1:0.5-0.75.

[0041] In the present invention, the filler is preferably mannitol; the lubricant preferably comprises polyethylene glycol 6000 and L-leucine; and the sweetener is preferably talose.

[0042] In the present invention, the mass ratio of polyethylene glycol 6000 to L-leucine is preferably 1 to 5:1, more preferably 2 to 4:1, and even more preferably 2.5 to 3:1.

[0043] The present invention also provides a method for preparing the effervescent tablet containing povidone, comprising the following steps:

[0044] (1) heating polyethylene glycol 6000 to obtain melted polyethylene glycol 6000; mixing the melted polyethylene glycol 6000 and an alkali source, and sequentially cooling, crushing and sieving to obtain first particles;

[0045] (2) mixing vitamin C, vitamin E, aloe vera freeze-dried powder, an acid source, povidone, ethanol and gallic acid to prepare a soft material, and sieving and drying the mixture in sequence to obtain a second granule;

[0046] (3) mixing the first granules, the second granules, the filler, L-leucine and the sweetener, and tableting to obtain the effervescent tablet containing povidone;

[0047] There is no specific order between step (1) and step (2).

[0048] In the present invention, the heating temperature in step (1) is preferably 70-80°C, more preferably 72-78°C, and more preferably 75-76°C; the target cooling temperature is preferably 20-30°C, more preferably 22-28°C, and more preferably 25-26°C; the mesh size of the sieve is preferably 60-100 mesh, more preferably 70-90 mesh, and more preferably 80 mesh.

[0049] In the present invention, during the mixing in step (2), preferably, PVP K30 and ethanol are first mixed to obtain an ethanol solution of PVP K30; and then the ethanol solution of PVP K30 is mixed with the other components in step (2).

[0050] In the present invention, the mesh size of the sieve in step (2) is preferably 15 to 30 meshes, more preferably 20 to 26 meshes, and more preferably 25 meshes; the drying temperature is preferably 40 to 60°C, more preferably 45 to 55°C, and more preferably 50°C.

[0051] In the present invention, the tabletting temperature in step (3) is preferably ≤25°C, more preferably ≤22°C, and more preferably ≤20°C; the tabletting humidity is preferably ≤30%, more preferably ≤25%, and more preferably ≤22%.

[0052] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0053] Example 1

[0054] The components and their weight fractions in this embodiment are:

[0055] 20 parts of vitamin C, 9 parts of vitamin E, 20 parts of aloe vera freeze-dried powder, 30 parts of citric acid, 20 parts of zinc carbonate, 15 parts of sodium bicarbonate, 3 parts of povidone K30, 30 parts of ethanol, 15 parts of mannitol, 10 parts of polyethylene glycol 6000, 2 parts of L-leucine, 3 parts of talose and 0.3 parts of gallic acid;

[0056] Polyethylene glycol 6000 is heated at 75°C until it is melted to obtain molten polyethylene glycol 6000; the molten polyethylene glycol 6000, zinc carbonate and sodium bicarbonate are mixed, naturally cooled to 25°C, crushed and passed through an 80-mesh sieve to obtain first particles; polyvinylpyrrolidone K30 and ethanol are mixed to obtain an ethanol solution of polyvinylpyrrolidone K30; vitamin C, vitamin E, aloe lyophilized powder, citric acid, the ethanol solution of polyvinylpyrrolidone K30 and gallic acid are mixed to prepare a soft material, passed through a 20-mesh sieve, and then dried at 50°C to obtain second particles; the first particles, the second particles, mannitol, L-leucine and talose are mixed, tabletted at a temperature of 20°C and a humidity of 22%, and packaged to obtain an effervescent tablet containing polyvinylpyrrolidone.

[0057] Example 2

[0058] The components and their weight fractions in this embodiment are:

[0059] 17 parts of vitamin C, 7 parts of vitamin E, 15 parts of aloe vera freeze-dried powder, 25 parts of citric acid, 20 parts of zinc carbonate, 10 parts of sodium bicarbonate, 2 parts of povidone K30, 20 parts of ethanol, 10 parts of mannitol, 8.2 parts of polyethylene glycol 6000, 1.8 parts of L-leucine, 2 parts of talose and 0.1 parts of gallic acid;

[0060] Polyethylene glycol 6000 is heated at 76°C until it is melted to obtain molten polyethylene glycol 6000; the molten polyethylene glycol 6000, zinc carbonate and sodium bicarbonate are mixed, naturally cooled to 25°C, crushed and passed through a 90-mesh sieve to obtain first particles; polyvinylpyrrolidone K30 and ethanol are mixed to obtain an ethanol solution of polyvinylpyrrolidone K30; vitamin C, vitamin E, aloe lyophilized powder, citric acid, the ethanol solution of polyvinylpyrrolidone K30 and gallic acid are mixed to prepare a soft material, passed through a 30-mesh sieve, and then dried at 55°C to obtain second particles; the first particles, the second particles, mannitol, L-leucine and talose are mixed, tabletted at a temperature of 22°C and a humidity of 25%, and packaged to obtain an effervescent tablet containing polyvinylpyrrolidone.

[0061] Example 3

[0062] The components and their weight fractions in this embodiment are:

[0063] 25 parts of vitamin C, 12 parts of vitamin E, 25 parts of aloe vera freeze-dried powder, 45 parts of citric acid, 25 parts of zinc carbonate, 20 parts of sodium bicarbonate, 5 parts of povidone K30, 50 parts of ethanol, 20 parts of mannitol, 15 parts of polyethylene glycol 6000, 3 parts of L-leucine, 5 parts of talose and 0.8 parts of gallic acid;

[0064] Polyethylene glycol 6000 is heated at 78°C until it is melted to obtain molten polyethylene glycol 6000; the molten polyethylene glycol 6000, zinc carbonate and sodium bicarbonate are mixed, naturally cooled to 30°C, crushed and passed through an 80-mesh sieve to obtain first particles; polyvinylpyrrolidone K30 and ethanol are mixed to obtain an ethanol solution of polyvinylpyrrolidone K30; vitamin C, vitamin E, aloe lyophilized powder, citric acid, the ethanol solution of polyvinylpyrrolidone K30 and gallic acid are mixed to prepare a soft material, passed through a 20-mesh sieve, and then dried at 50°C to obtain second particles; the first particles, the second particles, mannitol, L-leucine and talose are mixed, tabletted at a temperature of 20°C and a humidity of 20%, and packaged to obtain an effervescent tablet containing polyvinylpyrrolidone.

[0065] Comparative Example 1

[0066] The other conditions in Example 1 are kept unchanged, and mannitol is replaced by sucrose to obtain an effervescent tablet.

[0067] Comparative Example 2

[0068] The other conditions in Example 1 were kept unchanged, and the addition of talose and gallic acid was omitted to obtain an effervescent tablet.

[0069] Comparative Example 3

[0070] The components and their mass fractions in this comparative example are:

[0071] 20 parts of vitamin C, 9 parts of vitamin E, 20 parts of aloe vera freeze-dried powder, 30 parts of citric acid, 20 parts of zinc carbonate, 15 parts of sodium bicarbonate, 3 parts of ethyl cellulose, 15 parts of mannitol, 10 parts of polyethylene glycol 6000, 2 parts of L-leucine, 3 parts of talose and 0.3 parts of gallic acid;

[0072] Polyethylene glycol 6000 is heated at 75° C. to be melted to obtain molten polyethylene glycol 6000; the molten polyethylene glycol 6000, zinc carbonate and sodium bicarbonate are mixed, naturally cooled to 25° C., crushed and passed through an 80-mesh sieve to obtain first particles; vitamin C, vitamin E, aloe lyophilized powder, citric acid, ethyl cellulose and gallic acid are mixed, crushed and passed through a 20-mesh sieve to obtain second particles; the first particles, the second particles, mannitol, L-leucine and talose are mixed, tabletted at a temperature of 20° C. and a humidity of 22%, and packaged to obtain effervescent tablets.

[0073] Comparative Example 4

[0074] The components and their mass fractions in this comparative example are:

[0075] 25 parts of vitamin C, 12 parts of vitamin E, 25 parts of aloe vera freeze-dried powder, 45 parts of citric acid, 25 parts of zinc carbonate, 20 parts of sodium bicarbonate, 5 parts of povidone K30, 50 parts of ethanol, 20 parts of mannitol, 3 parts of L-leucine, 5 parts of talose and 0.8 parts of gallic acid;

[0076] Povidone K30 and ethanol are mixed to obtain an ethanol solution of povidone K30; a first portion of the ethanol solution of povidone K30 (the first portion of the ethanol solution of povidone K30 accounts for 1 / 2 of the volume of the entire ethanol solution of povidone K30), zinc carbonate and sodium bicarbonate are mixed to form a soft material, which is passed through a 20-mesh sieve and then dried at 50° C. to obtain first particles; vitamin C, vitamin E, aloe freeze-dried powder, citric acid, the remaining ethanol solution of povidone K30 and gallic acid are mixed to form a soft material, which is passed through a 20-mesh sieve and then dried at 50° C. to obtain second particles; the first particles, the second particles, mannitol, L-leucine and talose are mixed, tabletted at a temperature of 20° C. and a humidity of 20%, and packaged to obtain effervescent tablets.

[0077] Comparative Example 5

[0078] The components and their weight fractions in this comparative example are the same as those in Example 1.

[0079] The components are directly mixed, tableted and packaged to obtain effervescent tablets.

[0080] The effervescent tablets containing povidone prepared in Examples 1 to 3 and the effervescent tablets prepared in Comparative Examples 1 to 5 were subjected to performance tests, wherein the disintegration time was determined with reference to the "0921 Disintegration Time Test Method" in Part IV of the "Chinese Pharmacopoeia (2020 Edition)"; the method for determining the vitamin C content was based on Part II of the 2010 edition of the "Pharmacopoeia of the People's Republic of China", and the chromatographic conditions were as follows: the chromatographic column was a Diamonsil C18 column (250 mm × 4.6 mm, 5 μm), the mobile phase was methanol-20 mmol / L potassium dihydrogen phosphate buffer solution (35:65, phosphoric acid adjusted to pH 3.0), and the flow rate was 1.0 mL / min; the detection wavelength was 280 nm, and the injection volume was 10 μL; 3 months later refers to the effervescent tablets being sealed in double-layer plastic bags and aluminum foil bags, and then placed in an environment with a temperature of 40 ° C and a relative humidity of 75% for 3 months; the performance test results of different effervescent tablets are obtained, as shown in Table 1.

[0081] Table 1 Performance test results of different effervescent tablets

[0082]

[0083] It can be seen from the above embodiments that the present invention provides an effervescent tablet containing povidone, comprising the following components in parts by weight: 5 to 30 parts of vitamin C, 2 to 15 parts of vitamin E, 10 to 35 parts of aloe freeze-dried powder, 10 to 60 parts of acid source, 5 to 50 parts of alkali source, 1 to 7 parts of povidone, 10 to 60 parts of ethanol, 3 to 25 parts of filler, 1 to 20 parts of lubricant, 1 to 10 parts of sweetener and 0.1 to 1.5 parts of gallic acid. The addition of aloe vera freeze-dried powder prolongs the half-life of vitamin C and vitamin E in plasma, and improves the absorption and utilization efficiency of vitamins in effervescent tablets; specific types of fillers reduce the hygroscopicity of acid sources, and the two work together to improve the disintegration effect and stability of effervescent tablets; the addition of povidone and ethanol increases the disintegration rate of effervescent tablets, ensuring that the effervescent tablets have a good appearance and uniform size; in addition, specific types of fillers, sweeteners, povidone and gallic acid work synergistically with each other to further improve the stability of the effervescent tablets.

[0084] The present invention also provides a method for preparing an effervescent tablet containing povidone, comprising the following steps: heating polyethylene glycol 6000 to obtain molten polyethylene glycol 6000; mixing the molten polyethylene glycol 6000 with an alkali source, sequentially cooling, crushing and sieving to obtain first particles; mixing vitamin C, vitamin E, aloe lyophilized powder, acid source, povidone, ethanol and gallic acid to make a soft material, sequentially sieving and drying to obtain second particles; mixing the first particles, the second particles, a filler, L-leucine and a sweetener, and tableting to obtain an effervescent tablet containing povidone. The present invention encapsulates the alkali source with polyethylene glycol 6000 and the acid source with povidone, and finally prepares an effervescent tablet with good appearance, excellent stability and fast disintegration speed in the present application by reasonably setting each process and coordinating each component of a specific type and amount.

[0085] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. An effervescent tablet comprising povidone, characterized in that: Contains the following components in parts by weight: 5-30 parts of vitamin C, 2-15 parts of vitamin E, 10-35 parts of freeze-dried aloe powder, 10-60 parts of acid source, 5-50 parts of alkali source, 1-7 parts of povidone, 10-60 parts of ethanol, 3-25 parts of filler, 1-20 parts of lubricant, 1-10 parts of sweetener and 0.1-1.5 parts of gallic acid.

2. The effervescent tablet comprising povidone as claimed in claim 1, characterized in that The acid source is citric acid; the alkali source comprises zinc carbonate and sodium bicarbonate.

3. The effervescent tablet comprising povidone as claimed in claim 2, characterized in that The mass ratio of the zinc carbonate to the sodium bicarbonate is 1:0.1-1.

4. The effervescent tablet comprising povidone as claimed in claim 2 or 3, characterized in that The filler is mannitol; the lubricant comprises polyethylene glycol 6000 and L-leucine; and the sweetener is talose.

5. The effervescent tablet comprising povidone as claimed in claim 4, characterized in that The mass ratio of polyethylene glycol 6000 to L-leucine is 1-5:

1.

6. The method for preparing an effervescent tablet containing povidone according to any one of claims 1 to 5, characterized in that: It includes the following steps: (1) heating polyethylene glycol 6000 to obtain melted polyethylene glycol 6000; mixing the melted polyethylene glycol 6000 and an alkali source, and sequentially cooling, crushing and sieving to obtain first particles; (2) mixing vitamin C, vitamin E, aloe vera freeze-dried powder, an acid source, povidone, ethanol and gallic acid to prepare a soft material, and sieving and drying the mixture in sequence to obtain a second granule; (3) mixing the first granules, the second granules, the filler, L-leucine and the sweetener, and tableting to obtain the effervescent tablet containing povidone; There is no specific order between step (1) and step (2).

7. The method for preparing an effervescent tablet containing povidone as claimed in claim 6, characterized in that: The heating temperature in step (1) is 70-80° C., the target cooling temperature is 20-30° C., and the mesh size of the sieve is 60-100 meshes.

8. The method for preparing an effervescent tablet containing povidone according to claim 6 or 7, characterized in that: The mesh size of the sieving in step (2) is 15 to 30 meshes, and the drying temperature is 40 to 60°C.

9. The method for preparing an effervescent tablet containing povidone as claimed in claim 8, characterized in that: The tabletting temperature in step (3) is ≤25°C, and the tabletting humidity is ≤30%.